Novavax Inc.
Organization details
- Legal name
- Novavax Inc.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2836 — Biological Products, (No Diagnostic Substances)
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Gaithersburg
- Headquarters state / province
- Maryland
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- NVAX
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001000694
- EIN
- 22-2816046
- Wikidata ID
- Q17072200
Board of directors
-
Charles W. Newton · DirectorSince 2025
-
David M. Mott · DirectorSince 2023
-
Gregg H. Alton · DirectorSince 2023
-
James F. Young · DirectorSince 2023
-
John C. Jacobs · Director · President and CEOSince 2023
-
John W. Shiver · DirectorSince 2025
-
Margaret G. Mcglynn · DirectorSince 2023
-
Rachel K. King · DirectorSince 2023
-
Richard Douglas · DirectorSince 2023
-
Richard J. Rodgers · DirectorSince 2023
Chief executives
Weak · grade F
Out of 100, from shareholder return, dividends, growth and acquisitions.
Partial: only 20% of the scoring weight is on file.
- Revenue growth 20%
- 0
-17.2% a year in revenue
20% of the scoring weight is on file. Figures cover December 2022 – December 2025.
Director election results
Annual meeting of June 18, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
58.7%
-
60.4%
-
61.6%
Board connections
7 of this board's directors also sit on 12 other boards. 12 are in the same sector.
-
Ardelyx Inc. Same sectorvia David M. Mott and Richard J. Rodgers
-
Aldeyra Therapeutics Inc. Same sectorvia Richard Douglas
-
Coherus Oncology Inc. Same sectorvia Charles W. Newton
-
Corcept Therapeutics Incorporated Same sectorvia Gregg H. Alton
-
Crescent Biopharma Inc. Same sectorvia Rachel K. King
-
Fulcrum Therapeutics Inc. Same sectorvia Rachel K. King
-
Keros Therapeutics Inc. Same sectorvia Charles W. Newton
-
Lunai Bioworks Inc. Same sectorvia Gregg H. Alton
-
MaxCyte Inc. Same sectorvia Richard Douglas
-
Opus Genetics Inc. Same sectorvia Richard J. Rodgers
-
Sagimet Biosciences Inc. Same sectorvia Richard J. Rodgers
-
Vertex Pharmaceuticals Incorporated Same sectorvia Margaret G. Mcglynn
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 20, 2026 | Richard J. Rodgers Director | Option exercise | +18,880 | — | — |
| Jun 20, 2026 | Rachel K. King Director | Option exercise | +18,880 | — | — |
| Jun 20, 2026 | Richard Douglas Director | Option exercise | +18,880 | — | — |
| Jun 20, 2026 | Margaret G. Mcglynn Director | Option exercise | +18,880 | — | — |
| Jun 20, 2026 | David M. Mott Director | Option exercise | +18,880 | — | — |
| Jun 20, 2026 | Gregg H. Alton Director | Option exercise | +18,880 | — | — |
| Apr 25, 2026 | Charles W. Newton Director | Option exercise | +9,520 | — | — |
| Mar 10, 2026 | John W. Shiver Director | Option exercise | +7,947 | — | — |
| Mar 7, 2026 | Kelly James Patrick Officer (EVP, CFO and Treasurer) | Option exercise | +12,223 | — | — |
| Mar 7, 2026 | Kelly James Patrick Officer (EVP, CFO and Treasurer) | Shares withheld for tax | −5,904 | $9.98 | $58,922 |
| Mar 3, 2026 | Kelly James Patrick Officer (EVP, CFO and Treasurer) | Option exercise | +43,167 | — | — |
| Mar 3, 2026 | John C. Jacobs Director, Officer (President and CEO) | Option exercise | +150,167 | — | — |
| Mar 3, 2026 | O'Hara Elaine Officer (EVP, Chief Strategy Officer) | Option exercise | +56,334 | — | — |
| Mar 3, 2026 | Casey Mark J Officer (EVP, Chief Legal Officer) | Option exercise | +37,500 | — | — |
| Mar 3, 2026 | Draghia-Akli Ruxandra Officer (EVP, Research & Development) | Option exercise | +26,667 | — | — |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Novavax Inc.
Who is the CEO of Novavax Inc.?
John C. Jacobs has been Novavax Inc.'s President and CEO since January 2023.
How many directors are on Novavax Inc.'s board?
Novavax Inc.'s board has 10 directors: Charles W. Newton, David M. Mott, Gregg H. Alton, James F. Young, John C. Jacobs, John W. Shiver, Margaret G. Mcglynn, Rachel K. King, Richard Douglas and Richard J. Rodgers.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="novavax-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.